SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-21-003670
Filing Date
2021-05-20
Accepted
2021-05-20 16:46:20
Documents
1
Period of Report
2021-05-18

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 12522
  Complete submission text file 0001562180-21-003670.txt   13948
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Issuer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O SYNDAX PHARMACEUTICALS, INC. TOTTEN POND ROAD, SUITE 140 WALTHAM MA 02451
Business Address
Egros Fabrice (Reporting) CIK: 0001597085 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37708 | Film No.: 21945086